Five South Koreans die after getting flu shots, stirring coronavirus vaccine fears

Officials last month announced plans to procure 20 per cent more flu vaccines for the winter than the previous year to inoculate 30 million people

Ensuring public trust in vaccines has become a major global challenge this year, as some countries rush to approve experimental Covid-19 shots

2-MIN READ2-MIN

Even before the coronavirus pandemic, trust in vaccines was a growing challenge for public health bodies. Photo: AFP

Published: 6:09pm, 21 Oct 2020Updated: 1:05pm, 25 Nov 2020

Five people have died after getting flu shots in South Korea in the past week, authorities said, raising concerns over the vaccine’s safety just as the seasonal inoculation programme is expanded to head off potential Covid-19 complications.

Authorities said there was no reason to believe the deaths were linked to the vaccine but an investigation, including post mortems, was under way.

“It makes it hard for us to put out a categorical statement,” Vice Health Minister Kim Gang-lip told a briefing on Wednesday about the deaths, which include a 17-year-old boy and a man in his 70s.

Coming just weeks after the roll-out of the national vaccine programme was suspended over safety worries, the deaths have dominated headlines in South Korea.

Officials last month announced plans to procure 20 per cent more flu vaccines for the winter than the previous year to inoculate 30 million people in a bid to prevent the health system being overloaded by patients with flu and Covid-19 exposure.

However, the start of a free jab programme for around 19 million eligible people was suspended for three weeks after it was discovered that some 5 million doses, which need to be refrigerated, had been exposed to room temperature while being transported to a medical facility.

Boosting public trust in vaccines has become a major global challenge this year, as some countries rush to approve experimental Covid-19 vaccines before full safety and efficacy studies have been completed.